156 related articles for article (PubMed ID: 34008212)
1. S100A6 represses Calu-6 lung cancer cells growth via inhibiting cell proliferation, migration, invasion and enhancing apoptosis.
Wang T; Han S; Du G
Cell Biochem Funct; 2021 Aug; 39(6):771-779. PubMed ID: 34008212
[TBL] [Abstract][Full Text] [Related]
2. S100A6 could not promote the differentiation of Calu-6 lung cancer cell line.
Li J; Wang T; Dang D
Ann Med Surg (Lond); 2024 May; 86(5):2644-2650. PubMed ID: 38694326
[TBL] [Abstract][Full Text] [Related]
3. S100A6 protein: functional roles.
Donato R; Sorci G; Giambanco I
Cell Mol Life Sci; 2017 Aug; 74(15):2749-2760. PubMed ID: 28417162
[TBL] [Abstract][Full Text] [Related]
4. S100A6 promotes the development of thyroid cancer and inhibits apoptosis of thyroid cancer cells through the PI3K/AKT/mTOR pathway.
Chen B; Zheng D; Liu C; Bhandari A; Hirachan S; Shen C; Mainali S; Li H; Jiang W; Xu J; Zhang X; Tang K; Zhang W
Pathol Res Pract; 2023 Feb; 242():154325. PubMed ID: 36680929
[TBL] [Abstract][Full Text] [Related]
5. The Calcium-Binding Protein S100A6 Accelerates Human Osteosarcoma Growth by Promoting Cell Proliferation and Inhibiting Osteogenic Differentiation.
Li Y; Wagner ER; Yan Z; Wang Z; Luther G; Jiang W; Ye J; Wei Q; Wang J; Zhao L; Lu S; Wang X; Mohammed MK; Tang S; Liu H; Fan J; Zhang F; Zou Y; Song D; Liao J; Haydon RC; Luu HH; He TC
Cell Physiol Biochem; 2015; 37(6):2375-92. PubMed ID: 26646427
[TBL] [Abstract][Full Text] [Related]
6. S100A6 as a potential serum prognostic biomarker and therapeutic target in gastric cancer.
Zhang J; Zhang K; Jiang X; Zhang J
Dig Dis Sci; 2014 Sep; 59(9):2136-44. PubMed ID: 24705642
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of S100A6 in patients with endometriosis and its role in ectopic endometrial stromal cells.
Peng Y; Lin J; Ma J; Lin K; Xu K; Lin J
Gynecol Endocrinol; 2018 Sep; 34(9):815-820. PubMed ID: 29544367
[TBL] [Abstract][Full Text] [Related]
8. The Role of S100A6 in Human Diseases: Molecular Mechanisms and Therapeutic Potential.
Yang F; Ma J; Zhu D; Wang Z; Li Y; He X; Zhang G; Kang X
Biomolecules; 2023 Jul; 13(7):. PubMed ID: 37509175
[TBL] [Abstract][Full Text] [Related]
9. [Regulation mechanism study of S100A6 on invasion and metastasis in gastric cancer].
Li J; Wang XH; Li ZY; Bu ZD; Wu AW; Zhang LH; Wu XJ; Zong XL; Ji JF
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Nov; 16(11):1096-101. PubMed ID: 24277409
[TBL] [Abstract][Full Text] [Related]
10. S100A6 promotes proliferation of intrahepatic cholangiocarcinoma cells via the activation of the p38/MAPK pathway.
Zheng S; Shen H; Jia Q; Jing C; Lin J; Zhang M; Zhang X; Zhang B; Liu Y
Future Oncol; 2017 Oct; 13(23):2053-2063. PubMed ID: 28984474
[TBL] [Abstract][Full Text] [Related]
11. S100A6 Regulates Endothelial Cell Cycle Progression by Attenuating Antiproliferative Signal Transducers and Activators of Transcription 1 Signaling.
Lerchenmüller C; Heißenberg J; Damilano F; Bezzeridis VJ; Krämer I; Bochaton-Piallat ML; Hirschberg K; Busch M; Katus HA; Peppel K; Rosenzweig A; Busch H; Boerries M; Most P
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1854-67. PubMed ID: 27386938
[TBL] [Abstract][Full Text] [Related]
12. S100A6 inhibits MDM2 to suppress breast cancer growth and enhance sensitivity to chemotherapy.
Qi M; Yi X; Yue B; Huang M; Zhou S; Xiong J
Breast Cancer Res; 2023 May; 25(1):55. PubMed ID: 37217945
[TBL] [Abstract][Full Text] [Related]
13. Current view on cellular function of S100A6 and its ligands, CacyBP/SIP and Sgt1.
Filipek A; Leśniak W
Postepy Biochem; 2018 Oct; 64(3):242-252. PubMed ID: 30656909
[TBL] [Abstract][Full Text] [Related]
14. Blocking the interface region amongst S100A6 and RAGE V domain via S100B protein.
Sung HY; Dowarha D; Chou RH; Yu C
Biochem Biophys Res Commun; 2020 Dec; 533(3):332-337. PubMed ID: 32958253
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation, modification, and translocation of S100A6 induced by exposure to ionizing radiation revealed by proteomics profiling.
Orre LM; Pernemalm M; Lengqvist J; Lewensohn R; Lehtiö J
Mol Cell Proteomics; 2007 Dec; 6(12):2122-31. PubMed ID: 17785350
[TBL] [Abstract][Full Text] [Related]
16. Proteomics detection of S100A6 in tumor tissue interstitial fluid and evaluation of its potential as a biomarker of cholangiocarcinoma.
Onsurathum S; Haonon O; Pinlaor P; Pairojkul C; Khuntikeo N; Thanan R; Roytrakul S; Pinlaor S
Tumour Biol; 2018 Apr; 40(4):1010428318767195. PubMed ID: 29629840
[TBL] [Abstract][Full Text] [Related]
17. S100 calcium-binding protein A6 promotes epithelial-mesenchymal transition through β-catenin in pancreatic cancer cell line.
Chen X; Liu X; Lang H; Zhang S; Luo Y; Zhang J
PLoS One; 2015; 10(3):e0121319. PubMed ID: 25799022
[TBL] [Abstract][Full Text] [Related]
18. Interaction of S100A6 with Target Proteins In Vitro and in Living Cells.
Sakane K; Yamaguchi F; Tsuchiya M; Kondo R; Kanayama N; Magari M; Hatano N; Kobayashi R; Tokumitsu H
Methods Mol Biol; 2019; 1929():367-377. PubMed ID: 30710285
[TBL] [Abstract][Full Text] [Related]
19. High Expression of S100A6 Predicts Unfavorable Prognosis of Lung Squamous Cell Cancer.
He X; Xu X; Khan AQ; Ling W
Med Sci Monit; 2017 Oct; 23():5011-5017. PubMed ID: 29053662
[TBL] [Abstract][Full Text] [Related]
20. Effects of S100A6 gene silencing on the biological features of eutopic endometrial stromal cells and β‑catenin expression.
Zhang X; Liu Z; Chen M; Cao Q; Huang D
Mol Med Rep; 2017 Mar; 15(3):1279-1285. PubMed ID: 28075439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
